Click for best price
Pediatric Drugs Vaccines Market Size, Share 2023
Market Analysis and Insights: Global Pediatric Drugs Vaccines Market
The global Pediatric Drugs Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pediatric Drugs Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pediatric Drugs Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pediatric Drugs Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pediatric Drugs Vaccines market.
Global Pediatric Drugs Vaccines Scope and Market Size
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2032. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Segment by Application
Newborn
Infant
Child
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Pediatric Drugs Vaccines product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Pediatric Drugs Vaccines, with price, sales, revenue, and global market share of Pediatric Drugs Vaccines from 2019 to 2022.
Chapter 3, the Pediatric Drugs Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pediatric Drugs Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Pediatric Drugs Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pediatric Drugs Vaccines.
Chapter 13, 14, and 15, to describe Pediatric Drugs Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Pediatric Drugs Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Pediatric Drugs and Vaccines Market Research Report 2023 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
100 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Pediatric Drugs and Vaccines Market Overview
1.1 Product Overview and Scope of Pediatric Drugs and Vaccines
1.2 Pediatric Drugs and Vaccines Segment by Type
1.2.1 Global Pediatric Drugs and Vaccines Sales Growth Rate Comparison by Type (2023-2032)
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Mumps
1.2.8 Others
1.3 Pediatric Drugs and Vaccines Segment by Application
1.3.1 Global Pediatric Drugs and Vaccines Sales Comparison by Application: (2023-2032)
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.4 Global Pediatric Drugs and Vaccines Market Size Estimates and Forecasts
1.4.1 Global Pediatric Drugs and Vaccines Revenue 2018-2032
1.4.2 Global Pediatric Drugs and Vaccines Sales 2018-2032
1.4.3 Pediatric Drugs and Vaccines Market Size by Region: 2018 Versus 2022 Versus 2032
2 Pediatric Drugs and Vaccines Market Competition by Manufacturers
2.1 Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pediatric Drugs and Vaccines Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Pediatric Drugs and Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Pediatric Drugs and Vaccines Market Competitive Situation and Trends
2.5.1 Pediatric Drugs and Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pediatric Drugs and Vaccines Players Market Share by Revenue
2.5.3 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pediatric Drugs and Vaccines Retrospective Market Scenario by Region
3.1 Global Pediatric Drugs and Vaccines Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Pediatric Drugs and Vaccines Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.3.1 North America Pediatric Drugs and Vaccines Sales by Country
3.3.2 North America Pediatric Drugs and Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.4.1 Europe Pediatric Drugs and Vaccines Sales by Country
3.4.2 Europe Pediatric Drugs and Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pediatric Drugs and Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Region
3.5.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.6.1 Latin America Pediatric Drugs and Vaccines Sales by Country
3.6.2 Latin America Pediatric Drugs and Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Country
3.7.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pediatric Drugs and Vaccines Historic Market Analysis by Type
4.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2018-2023)
4.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2018-2023)
4.3 Global Pediatric Drugs and Vaccines Price by Type (2018-2023)
5 Global Pediatric Drugs and Vaccines Historic Market Analysis by Application
5.1 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2018-2023)
5.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2018-2023)
5.3 Global Pediatric Drugs and Vaccines Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Merck & Co., Inc. (USA)
6.1.1 Merck & Co., Inc. (USA) Corporation Information
6.1.2 Merck & Co., Inc. (USA) Description and Business Overview
6.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.1.5 Merck & Co., Inc. (USA) Recent Developments/Updates
6.2 Abbott Laboratories (USA)
6.2.1 Abbott Laboratories (USA) Corporation Information
6.2.2 Abbott Laboratories (USA) Description and Business Overview
6.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolio
6.2.5 Abbott Laboratories (USA) Recent Developments/Updates
6.3 Amgen, Inc. (USA)
6.3.1 Amgen, Inc. (USA) Corporation Information
6.3.2 Amgen, Inc. (USA) Description and Business Overview
6.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.3.5 Amgen, Inc. (USA) Recent Developments/Updates
6.4 Eli Lilly and Company (USA)
6.4.1 Eli Lilly and Company (USA) Corporation Information
6.4.2 Eli Lilly and Company (USA) Description and Business Overview
6.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolio
6.4.5 Eli Lilly and Company (USA) Recent Developments/Updates
6.5 F. Hoffmann-La Roche Ltd (Switzerland)
6.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
6.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview
6.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolio
6.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments/Updates
6.6 Genentech, Inc. (USA)
6.6.1 Genentech, Inc. (USA) Corporation Information
6.6.2 Genentech, Inc. (USA) Description and Business Overview
6.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.6.5 Genentech, Inc. (USA) Recent Developments/Updates
6.7 GlaxoSmithKline plc. (UK)
6.6.1 GlaxoSmithKline plc. (UK) Corporation Information
6.6.2 GlaxoSmithKline plc. (UK) Description and Business Overview
6.6.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Portfolio
6.7.5 GlaxoSmithKline plc. (UK) Recent Developments/Updates
6.8 Janssen Biologics B.V. (USA)
6.8.1 Janssen Biologics B.V. (USA) Corporation Information
6.8.2 Janssen Biologics B.V. (USA) Description and Business Overview
6.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.8.5 Janssen Biologics B.V. (USA) Recent Developments/Updates
6.9 Actelion Pharmaceuticals
6.9.1 Actelion Pharmaceuticals Corporation Information
6.9.2 Actelion Pharmaceuticals Description and Business Overview
6.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolio
6.9.5 Actelion Pharmaceuticals Recent Developments/Updates
6.10 AstraZeneca Plc. (UK)
6.10.1 AstraZeneca Plc. (UK) Corporation Information
6.10.2 AstraZeneca Plc. (UK) Description and Business Overview
6.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Portfolio
6.10.5 AstraZeneca Plc. (UK) Recent Developments/Updates
6.11 Boehringer Ingelheim GmbH (Germany)
6.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information
6.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Description and Business Overview
6.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolio
6.11.5 Boehringer Ingelheim GmbH (Germany) Recent Developments/Updates
6.12 Bristol-Myers Squibb Company (USA)
6.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
6.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolio
6.12.5 Bristol-Myers Squibb Company (USA) Recent Developments/Updates
6.13 Allergan, Inc. (USA)
6.13.1 Allergan, Inc. (USA) Corporation Information
6.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.13.5 Allergan, Inc. (USA) Recent Developments/Updates
6.14 Novartis AG (Switzerland)
6.14.1 Novartis AG (Switzerland) Corporation Information
6.14.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Description and Business Overview
6.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolio
6.14.5 Novartis AG (Switzerland) Recent Developments/Updates
6.15 Novo Nordisk A/S (Denmark)
6.15.1 Novo Nordisk A/S (Denmark) Corporation Information
6.15.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Description and Business Overview
6.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolio
6.15.5 Novo Nordisk A/S (Denmark) Recent Developments/Updates
6.16 Pfizer, Inc. (USA)
6.16.1 Pfizer, Inc. (USA) Corporation Information
6.16.2 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.16.5 Pfizer, Inc. (USA) Recent Developments/Updates
6.17 Sanofi S.A (France)
6.17.1 Sanofi S.A (France) Corporation Information
6.17.2 Sanofi S.A (France) Pediatric Drugs and Vaccines Description and Business Overview
6.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Portfolio
6.17.5 Sanofi S.A (France) Recent Developments/Updates
6.18 Shionogi Inc. (USA)
6.18.1 Shionogi Inc. (USA) Corporation Information
6.18.2 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.18.5 Shionogi Inc. (USA) Recent Developments/Updates
6.19 Takeda
6.19.1 Takeda Corporation Information
6.19.2 Takeda Pediatric Drugs and Vaccines Description and Business Overview
6.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Takeda Pediatric Drugs and Vaccines Product Portfolio
6.19.5 Takeda Recent Developments/Updates
7 Pediatric Drugs and Vaccines Manufacturing Cost Analysis
7.1 Pediatric Drugs and Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines
7.4 Pediatric Drugs and Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pediatric Drugs and Vaccines Distributors List
8.3 Pediatric Drugs and Vaccines Customers
9 Pediatric Drugs and Vaccines Market Dynamics
9.1 Pediatric Drugs and Vaccines Industry Trends
9.2 Pediatric Drugs and Vaccines Market Drivers
9.3 Pediatric Drugs and Vaccines Market Challenges
9.4 Pediatric Drugs and Vaccines Market Restraints
10 Global Market Forecast
10.1 Pediatric Drugs and Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pediatric Drugs and Vaccines by Type (2023-2032)
10.1.2 Global Forecasted Revenue of Pediatric Drugs and Vaccines by Type (2023-2032)
10.2 Pediatric Drugs and Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pediatric Drugs and Vaccines by Application (2023-2032)
10.2.2 Global Forecasted Revenue of Pediatric Drugs and Vaccines by Application (2023-2032)
10.3 Pediatric Drugs and Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pediatric Drugs and Vaccines by Region (2023-2032)
10.3.2 Global Forecasted Revenue of Pediatric Drugs and Vaccines by Region (2023-2032)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Pediatric Drugs and Vaccines Sales Growth Rate Comparison by Type (2023-2032) & (K Units) & (US$ Million)
Table 2. Global Pediatric Drugs and Vaccines Sales Growth Rate Comparison by Application (2023-2032) & (K Units) & (US$ Million)
Table 3. Global Pediatric Drugs and Vaccines Market Size by Region (US$ Million) (2018 VS 2022 VS 2032)
Table 4. Global Pediatric Drugs and Vaccines Market Competitive Situation by Manufacturers in 2022
Table 5. Global Pediatric Drugs and Vaccines Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Pediatric Drugs and Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market Pediatric Drugs and Vaccines Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers Pediatric Drugs and Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Pediatric Drugs and Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pediatric Drugs and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Drugs and Vaccines as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pediatric Drugs and Vaccines Sales by Region (2018-2023) & (K Units)
Table 16. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2018-2023)
Table 17. Global Pediatric Drugs and Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2018-2023)
Table 19. North America Pediatric Drugs and Vaccines Sales by Country (2018-2023) & (K Units)
Table 20. North America Pediatric Drugs and Vaccines Sales Market Share by Country (2018-2023)
Table 21. North America Pediatric Drugs and Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America Pediatric Drugs and Vaccines Revenue Market Share by Country (2018-2023)
Table 23. Europe Pediatric Drugs and Vaccines Sales by Country (2018-2023) & (K Units)
Table 24. Europe Pediatric Drugs and Vaccines Sales Market Share by Country (2018-2023)
Table 25. Europe Pediatric Drugs and Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific Pediatric Drugs and Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific Pediatric Drugs and Vaccines Revenue Market Share by Region (2018-2023)
Table 31. Latin America Pediatric Drugs and Vaccines Sales by Country (2018-2023) & (K Units)
Table 32. Latin America Pediatric Drugs and Vaccines Sales Market Share by Country (2018-2023)
Table 33. Latin America Pediatric Drugs and Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America Pediatric Drugs and Vaccines Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa Pediatric Drugs and Vaccines Revenue Market Share by Country (2018-2023)
Table 39. Global Pediatric Drugs and Vaccines Sales by Type (2018-2023) & (K Units)
Table 40. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2018-2023)
Table 41. Global Pediatric Drugs and Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Pediatric Drugs and Vaccines Revenue Share by Type (2018-2023)
Table 43. Global Pediatric Drugs and Vaccines Price by Type (2018-2023) & (USD/Unit)
Table 44. Global Pediatric Drugs and Vaccines Sales (K Units) by Application (2018-2023)
Table 45. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2018-2023)
Table 46. Global Pediatric Drugs and Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Pediatric Drugs and Vaccines Revenue Share by Application (2018-2023)
Table 48. Global Pediatric Drugs and Vaccines Price by Application (2018-2023) & (USD/Unit)
Table 49. Merck & Co., Inc. (USA) Corporation Information
Table 50. Merck & Co., Inc. (USA) Description and Business Overview
Table 51. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product
Table 53. Merck & Co., Inc. (USA) Recent Developments/Updates
Table 54. Abbott Laboratories (USA) Corporation Information
Table 55. Abbott Laboratories (USA) Description and Business Overview
Table 56. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product
Table 58. Abbott Laboratories (USA) Recent Developments/Updates
Table 59. Amgen, Inc. (USA) Corporation Information
Table 60. Amgen, Inc. (USA) Description and Business Overview
Table 61. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product
Table 63. Amgen, Inc. (USA) Recent Developments/Updates
Table 64. Eli Lilly and Company (USA) Corporation Information
Table 65. Eli Lilly and Company (USA) Description and Business Overview
Table 66. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product
Table 68. Eli Lilly and Company (USA) Recent Developments/Updates
Table 69. F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
Table 70. F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview
Table 71. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product
Table 73. F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments/Updates
Table 74. Genentech, Inc. (USA) Corporation Information
Table 75. Genentech, Inc. (USA) Description and Business Overview
Table 76. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product
Table 78. Genentech, Inc. (USA) Recent Developments/Updates
Table 79. GlaxoSmithKline plc. (UK) Corporation Information
Table 80. GlaxoSmithKline plc. (UK) Description and Business Overview
Table 81. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product
Table 83. GlaxoSmithKline plc. (UK) Recent Developments/Updates
Table 84. Janssen Biologics B.V. (USA) Corporation Information
Table 85. Janssen Biologics B.V. (USA) Description and Business Overview
Table 86. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product
Table 88. Janssen Biologics B.V. (USA) Recent Developments/Updates
Table 89. Actelion Pharmaceuticals Corporation Information
Table 90. Actelion Pharmaceuticals Description and Business Overview
Table 91. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product
Table 93. Actelion Pharmaceuticals Recent Developments/Updates
Table 94. AstraZeneca Plc. (UK) Corporation Information
Table 95. AstraZeneca Plc. (UK) Description and Business Overview
Table 96. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product
Table 98. AstraZeneca Plc. (UK) Recent Developments/Updates
Table 99. Boehringer Ingelheim GmbH (Germany) Corporation Information
Table 100. Boehringer Ingelheim GmbH (Germany) Description and Business Overview
Table 101. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product
Table 103. Boehringer Ingelheim GmbH (Germany) Recent Developments/Updates
Table 104. Bristol-Myers Squibb Company (USA) Corporation Information
Table 105. Bristol-Myers Squibb Company (USA) Description and Business Overview
Table 106. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product
Table 108. Bristol-Myers Squibb Company (USA) Recent Developments/Updates
Table 109. Allergan, Inc. (USA) Corporation Information
Table 110. Allergan, Inc. (USA) Description and Business Overview
Table 111. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product
Table 113. Allergan, Inc. (USA) Recent Developments/Updates
Table 114. Novartis AG (Switzerland) Corporation Information
Table 115. Novartis AG (Switzerland) Description and Business Overview
Table 116. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product
Table 118. Novartis AG (Switzerland) Recent Developments/Updates
Table 119. Novo Nordisk A/S (Denmark) Corporation Information
Table 120. Novo Nordisk A/S (Denmark) Description and Business Overview
Table 121. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product
Table 123. Novo Nordisk A/S (Denmark) Recent Developments/Updates
Table 124. Pfizer, Inc. (USA) Corporation Information
Table 125. Pfizer, Inc. (USA) Description and Business Overview
Table 126. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product
Table 128. Pfizer, Inc. (USA) Recent Developments/Updates
Table 129. Sanofi S.A (France) Corporation Information
Table 130. Sanofi S.A (France) Description and Business Overview
Table 131. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Sanofi S.A (France) Pediatric Drugs and Vaccines Product
Table 133. Sanofi S.A (France) Recent Developments/Updates
Table 134. Shionogi Inc. (USA) Corporation Information
Table 135. Shionogi Inc. (USA) Description and Business Overview
Table 136. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 137. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product
Table 138. Shionogi Inc. (USA) Recent Developments/Updates
Table 139. Takeda Corporation Information
Table 140. Takeda Description and Business Overview
Table 141. Takeda Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 142. Takeda Pediatric Drugs and Vaccines Product
Table 143. Takeda Recent Developments/Updates
Table 144. Production Base and Market Concentration Rate of Raw Material
Table 145. Key Suppliers of Raw Materials
Table 146. Pediatric Drugs and Vaccines Distributors List
Table 147. Pediatric Drugs and Vaccines Customers List
Table 148. Pediatric Drugs and Vaccines Market Trends
Table 149. Pediatric Drugs and Vaccines Market Drivers
Table 150. Pediatric Drugs and Vaccines Market Challenges
Table 151. Pediatric Drugs and Vaccines Market Restraints
Table 152. Global Pediatric Drugs and Vaccines Sales Forecast by Type (2023-2032) & (K Units)
Table 153. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Type (2023-2032)
Table 154. Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2023-2032) & (US$ Million)
Table 155. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Type (2023-2032)
Table 156. Global Pediatric Drugs and Vaccines Sales Forecast by Application (2023-2032) & (K Units)
Table 157. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Application (2023-2032)
Table 158. Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2023-2032) & (US$ Million)
Table 159. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Application (2023-2032)
Table 160. Global Pediatric Drugs and Vaccines Sales Forecast by Region (2023-2032) & (K Units)
Table 161. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Region (2023-2032)
Table 162. Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2023-2032) & (US$ Million)
Table 163. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Region (2023-2032)
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pediatric Drugs and Vaccines
Figure 2. Global Pediatric Drugs and Vaccines Market Share by Type in 2022 & 2032
Figure 3. Diphtheria Product Picture
Figure 4. Influenza Product Picture
Figure 5. Hepatitis Product Picture
Figure 6. Pneumococcal Diseases Product Picture
Figure 7. Meningococcal Diseases Product Picture
Figure 8. Mumps Product Picture
Figure 9. Others Product Picture
Figure 10. Global Pediatric Drugs and Vaccines Market Share by Application in 2022 & 2032
Figure 11. Newborn
Figure 12. Infant
Figure 13. Child
Figure 14. Global Pediatric Drugs and Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2032
Figure 15. Global Pediatric Drugs and Vaccines Market Size (2018-2032) & (US$ Million)
Figure 16. Global Pediatric Drugs and Vaccines Sales (2018-2032) & (K Units)
Figure 17. Pediatric Drugs and Vaccines Sales Share by Manufacturers in 2022
Figure 18. Global Pediatric Drugs and Vaccines Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Pediatric Drugs and Vaccines Players: Market Share by Revenue in 2022
Figure 20. Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2018-2023)
Figure 22. Global Pediatric Drugs and Vaccines Sales Market Share by Region in 2022
Figure 23. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2018-2023)
Figure 24. Global Pediatric Drugs and Vaccines Revenue Market Share by Region in 2022
Figure 25. U.S. Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 26. Canada Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. Germany Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. France Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. U.K. Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. Italy Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. Russia Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. China Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. Japan Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. South Korea Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. India Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. Australia Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Taiwan Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Indonesia Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Thailand Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Malaysia Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Philippines Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Vietnam Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. Mexico Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Brazil Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 45. Argentina Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 46. Turkey Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 47. Saudi Arabia Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 48. U.A.E Pediatric Drugs and Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 49. Sales Market Share of Pediatric Drugs and Vaccines by Type (2018-2023)
Figure 50. Manufacturing Cost Structure of Pediatric Drugs and Vaccines
Figure 51. Manufacturing Process Analysis of Pediatric Drugs and Vaccines
Figure 52. Pediatric Drugs and Vaccines Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
